Biogen Inc (NASDAQ:BIIB)
| 293.79 Delayed Data As of Apr 01 |  -23.11 / -7.30%Today’s Change | 215.78 Today|||52-Week Range 374.99 | -0.99% Year-to-Date |
Latest BIIB News | Press Releases
| So Your Biotech Announced Positive Phase 3 Results? Celebrating Could be Premature Apr 01 / MotleyFool.com - Paid Partner Content | Better Buy: AbbVie vs. Biogen Mar 24 / MotleyFool.com - Paid Partner Content |
| 4 Reasons Drug Stocks Are a Buy Right Now Mar 30 / MotleyFool.com - Paid Partner Content | Are These Warren Buffett Stocks a Buy at Beaten-Down Prices? Mar 23 / MotleyFool.com - Paid Partner Content |
| Bristol Myers Squibb's Multiple Sclerosis Drug, a Potential Blockbuster, Wins FDA Approval Mar 26 / MotleyFool.com - Paid Partner Content | Berkshire’s Recent Purchases Show Why Value Investing Still Works Mar 20 / MotleyFool.com - Paid Partner Content |
| 4 Reasons Biotech Stocks Are a Buy Right Now Mar 25 / MotleyFool.com - Paid Partner Content |
